These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8822476)

  • 21. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 2004 Apr; 309(1):109-18. PubMed ID: 14722316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
    Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of acute and chronic treatment with SCH 23390 on the spontaneous activity of midbrain dopamine neurons.
    Esposito E; Bunney BS
    Eur J Pharmacol; 1989 Mar; 162(1):109-13. PubMed ID: 2656273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
    Hether S; Misono K; Lessard A
    Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D1 dopamine receptor stimulation inhibits firing activity of midbrain dopamine neurons in reserpine treated rats: an effect eliminated after hemitransection of diencephalon.
    Sun BC; Chouvet G; Jin GZ
    Synapse; 1996 Sep; 24(1):29-38. PubMed ID: 9046074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with high doses of haloperidol fails to decrease the time course for the development of depolarization inactivation of midbrain dopamine neurons.
    Jiang LH; Tsai M; Wang RY
    Life Sci; 1988; 43(1):75-81. PubMed ID: 3386416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Sekine Y; Suzuki K; Ramachandran PV; Blackburn TP; Ashby CR
    Synapse; 2007 Feb; 61(2):72-7. PubMed ID: 17117425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):127-33. PubMed ID: 1321681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel atypical antipsychotic cariprazine demonstrates dopamine D
    Delcourte S; Ashby CR; Rovera R; Kiss B; Adham N; Farkas B; Haddjeri N
    CNS Neurosci Ther; 2018 Dec; 24(12):1129-1139. PubMed ID: 29729086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
    Rasmussen K; Czachura JF; Stockton ME; Howbert JJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):480-8. PubMed ID: 8423546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic treatment with SCH 23390 and haloperidol on spontaneous activity of dopamine neurones in substantia nigra pars compacta (SNC) and ventral tegmental area (VTA) in rats.
    Skarsfeldt T
    Eur J Pharmacol; 1988 Jan; 145(2):239-43. PubMed ID: 3280330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats.
    Skarsfeldt T
    Life Sci; 1988; 42(10):1037-44. PubMed ID: 2894601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR; Jiang LH; Wang RY
    Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats.
    Gifford AN; Gardner EL; Ashby CR
    Neuropsychobiology; 1997; 36(2):96-9. PubMed ID: 9267859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
    Sun BC; Jin GZ
    Biol Signals; 1992; 1(6):331-8. PubMed ID: 1307933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.